8
VIEWS
0
COMMENTS
 
SHARES
About this iReport
  • Not verified by CNN

  • Click to view junegirl1's profile
    Posted June 20, 2014 by
    junegirl1

    More from junegirl1

    Advancing innovative treatments

     
    Kala Pharmaceuticals, Inc. is advancing innovative treatments for ocular diseases addressing significant needs in both front and back of the eye based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology. Kala's topical ocular MPP formulations enhance penetration into ocular tissue by facilitating penetration through the mucus layer of tear film.

    Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering.

    For more information, please visit www.kalarx.com.
    Add your Story Add your Story